Evolus, Inc.
EOLS
Rank in Stocks
#13434
Evolus, Inc. is a performance beauty enterprise that furnishes the United... Evolus, Inc. is a performance beauty enterprise that furnishes the United States market with medical aesthetic solutions for healthcare professionals and their patients. A key product in its portfolio is Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation. This product is specifically designed for adults seeking the temporary smoothing of moderate to severe glabellar (frown) lines. Founded in 2012, Evolus, Inc. maintains its corporate headquarters in Newport Beach, California.
Share Price
$7.12
Last synced: 2026-10-16
Market Cap
$470.34M
Change (1 day)
-5.93%
Change (1 year)
-51.16%
Country
US
Trade Evolus, Inc. (EOLS)
Category
Healthcare
Market Capitalization of Evolus, Inc.(EOLS)
Market Cap: $470.34M
As of October 2026 Evolus, Inc. has a market cap of $470.34M. This makes Evolus, Inc. the world's 13434th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Evolus, Inc. from 2018 to 2026
EOLS compared with Top 5 Most Popular stocks